{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["DNA damage", "Momordica charantia", "anticancer", "apoptosis", "bitter melon", "medicinal applications."]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": [], "GeneralNote": [], "PMID": "29932035", "DateCompleted": {"Year": "2019", "Month": "08", "Day": "02"}, "DateRevised": {"Year": "2020", "Month": "02", "Day": "25"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": ["10.2174/1389203719666180622095800"], "Journal": {"ISSN": "1875-5550", "JournalIssue": {"Volume": "20", "Issue": "3", "PubDate": {"Year": "2019"}}, "Title": "Current protein & peptide science", "ISOAbbreviation": "Curr Protein Pept Sci"}, "ArticleTitle": "Emerging Antitumor Activities of the Bitter Melon (Momordica charantia).", "Pagination": {"StartPage": "296", "EndPage": "301", "MedlinePgn": "296-301"}, "Abstract": {"AbstractText": ["Bitter melon or bitter gourd (Momordica charantia) is a common vegetable in Asia and it is distinctive for its bitter taste. As an ingredient in folk medicine, research from different laboratories in recent years supports its potential medicinal applications with anti-tumor, anti-diabetic, anti-HIV activities in both in vitro and animal studies. In this short review, we summarize herein the recent progress in the antitumor aspect of bitter melon with a focus on the underlying molecular mechanisms. Further mechanistic studies as well as clinical trials are necessary to further verify its medicinal applications."], "CopyrightInformation": "Copyright\u00a9 Bentham Science Publishers; For any queries, please email at epub@benthamscience.net."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Molecular Gerontology, National Institute on Aging, NIH, United States."}], "LastName": "Fang", "ForeName": "Evandro Fei", "Initials": "EF"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Molecular Gerontology, National Institute on Aging, NIH, United States."}], "LastName": "Froetscher", "ForeName": "Lynn", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Molecular Gerontology, National Institute on Aging, NIH, United States."}], "LastName": "Scheibye-Knudsen", "ForeName": "Morten", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Molecular Gerontology, National Institute on Aging, NIH, United States."}], "LastName": "Bohr", "ForeName": "Vilhelm A", "Initials": "VA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Biomedical Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong."}], "LastName": "Wong", "ForeName": "Jack Ho", "Initials": "JH"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Biomedical Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong."}], "LastName": "Ng", "ForeName": "Tzi Bun", "Initials": "TB"}], "GrantList": [{"GrantID": "Z99 AG999999", "Agency": "Intramural NIH HHS", "Country": "United States"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "United Arab Emirates", "MedlineTA": "Curr Protein Pept Sci", "NlmUniqueID": "100960529", "ISSNLinking": "1389-2037"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["chemistry", "isolation & purification", "pharmacology"], "DescriptorName": "Antineoplastic Agents"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["chemistry"], "DescriptorName": "Momordica charantia"}, {"QualifierName": ["therapy"], "DescriptorName": "Neoplasms"}, {"QualifierName": [], "DescriptorName": "Phytotherapy"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}], "CoiStatement": "CONFLICT OF INTEREST. The authors declare no conflict of interest, financial or otherwise."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Fang EF; Ng TB Chapter 27: Achievements, questions arising and future outlook on the path to discover new medicinal compounds, In: Fang EF; Ng TB (Eds.) Antitumor potential and other emerging medicinal properties of natural compounds, Springer, Dordrecht, 2013."}, {"Citation": "Fang EF; Ng TB Ribonucleases of different origins with a wide spectrum of medicinal applications. Biochim. Biophys. Acta, 2011, 1815, 65\u201374.", "ArticleIdList": ["20843477"]}, {"Citation": "Newman DJ; Cragg GM; Snader KM Natural products as sources of new drugs over the period 1981\u20132002. J. Nat. Prod, 2003, 66, 1022\u20131037.", "ArticleIdList": ["12880330"]}, {"Citation": "Bauer R; Guo DA; Hylands P; Fan TP; Xu Q Chapter 25: The role of the GP-TCM research association to modernization and globalization of traditional Chinese Medicine, In: Fang EF; Ng TB (Eds.) Antitumor potential and other emerging medicinal properties of natural compounds, Springer, Dordrecht, 2013."}, {"Citation": "Fang EF; Ng TB Bitter gourd (Momordica charantia) is a cornucopia of health: A review of its credited antidiabetic, anti-HIV, and antitumor properties. Curr. Mol. Med, 2011, 11, 417\u2013436.", "ArticleIdList": ["21568930"]}, {"Citation": "Fang EF; Ng TB Can bitter gourd (Momordica charantia) be a novel therapy for human cancers?. Med. Aromat. Plants, 2012, 1, 1\u20132."}, {"Citation": "Zhang CZ; Fang EF; Zhang HT; Liu LL; Yun JP Momordica charantia lectin exhibits antitumor activity towards hepatocellular carcinoma. Invest New Drugs, 2015, 33(1), 1\u201311.", "ArticleIdList": ["25200916"]}, {"Citation": "Pan WL; Wong JH; Fang EF; Chan YS; Ng TB; Cheung RC Preferential cytotoxicity of the type I ribosome inactivating protein alpha-momorcharin on human nasopharyngeal carcinoma cells under normoxia and hypoxia. Biochem. Pharmacol, 2014, 89, 329\u2013339.", "ArticleIdList": ["PMC5937121", "24637239"]}, {"Citation": "Fang EF; Zhang CZ; Wong JH; Shen JY; Li CH; Ng TB The MAP30 protein from bitter gourd (Momordica charantia) seeds promotes apoptosis in liver cancer cells in vitro and in vivo. Cancer Lett., 2012, 324, 66\u201374.", "ArticleIdList": ["22579806"]}, {"Citation": "Fang EF; Zhang CZ; Zhang L; Fong WP; Ng TB In vitro and in vivo anticarcinogenic effects of RNase MC2, a ribonuclease isolated from dietary bitter gourd, toward human liver cancer cells. Int. J. Biochem. Cell. Biol, 2012, 44, 1351\u20131360.", "ArticleIdList": ["22554586"]}, {"Citation": "Fang EF; Ng TB Chapter 21: The bitter fruit with sweet health benefits: A comprehensive synopsis of recent research progress on medicinal properties of momordica charantia In: Fang EF; Ng TB (Eds.) Antitumor potential and other emerging medicinal properties of natural compounds, Dordrecht, 2013."}, {"Citation": "Wong CM; Yeung HW; Ng TB Screening of Trichosanthes kirilowii, Momordica charantia and Cucurbita maxima (family Cucurbitaceae) for compounds with antilipolytic activity. J. Ethnopharmacol, 1985, 13, 313\u2013321.", "ArticleIdList": ["4058034"]}, {"Citation": "Jilka C; Strifler B; Fortner GW; Hays EF; Takemoto DJ In vivo antitumor activity of the bitter melon (Momordica charantia). Cancer Res., 1983, 43, 5151\u20135155.", "ArticleIdList": ["6616452"]}, {"Citation": "Ray RB; Raychoudhuri A; Steele R; Nerurkar P Bitter melon (Momordica charantia) extract inhibits breast cancer cell proliferation by modulating cell cycle regulatory genes and promotes apoptosis. Cancer Res., 2010, 70, 1925\u20131931.", "ArticleIdList": ["20179194"]}, {"Citation": "Kwatra D; Subramaniam D; Ramamoorthy P; Standing D; Moran E; Velayutham R; Mitra A; Umar S; Anant S Methanolic extracts of bitter melon inhibit colon cancer stem cells by affecting energy homeostasis and autophagy. Evid Based Complement Alternat Med., 2013, 2013, 702869.", "ArticleIdList": ["PMC3606719", "23533514"]}, {"Citation": "Kaur M; Deep G; Jain AK; Raina K; Agarwal C; Wempe MF; Agarwal R Bitter melon juice activates cellular energy sensor AMP-activated protein kinase causing apoptotic death of human pancreatic carcinoma cell. Carcinogenesis, 2013, 34, 1585\u20131592.", "ArticleIdList": ["PMC3697895", "23475945"]}, {"Citation": "Somasagara RR; Deep G; Shrotriya S; Patel M; Agarwal C; Agarwal R Bitter melon juice targets molecular mechanisms underlying gemcitabine resistance in pancreatic cancer cells. Int. J. Oncol, 2015, 46, 1849\u20131857.", "ArticleIdList": ["PMC4356502", "25672620"]}, {"Citation": "Fang EF; Zhang CZ; Ng TB; Wong JH; Pan WL; Ye XJ; Chan YS; Fong WP Momordica charantia lectin, a type II ribosome inactivating protein, exhibits antitumor activity toward human nasopharyngeal carcinoma cells in vitro and in vivo. Cancer Prev. Res. (Phila), 2012, 5, 109\u2013121.", "ArticleIdList": ["21933914"]}, {"Citation": "Fan JM; Luo J; Xu J; Zhu S; Zhang Q; Gao DF; Xu YB; Zhang GP Effects of recombinant MAP30 on cell proliferation and apoptosis of human colorectal carcinoma LoVo cells. Mol. Biotechnol, 2008, 39, 79\u201386.", "ArticleIdList": ["18246454"]}, {"Citation": "Lee-Huang S; Huang PL; Lee-Huang P Chapter 8: The discovery of MAP30 and elucidation of its medicinal activities In: Fang EF; Ng TB; (Eds.) Antitumor potential and other emerging medicinal properties of natural compounds, Dordrecht, 2013."}, {"Citation": "Xiong SD; Yu K; Liu XH; Yin LH; Kirschenbaum A; Yao S; Narla G; DiFeo A; Wu JB; Yuan Y; Ho SM; Lam YW; Levine AC Ribosome-inactivating proteins isolated from dietary bitter melon induce apoptosis and inhibit histone deacetylase-1 selectively in premalignant and malignant prostate cancer cells. Int. J. Cancer, 2009, 125, 774\u2013782.", "ArticleIdList": ["PMC3778503", "19384952"]}, {"Citation": "Fang EF; Zhang CZ; Fong WP; Ng TB RNase MC2: A new Momordica charantia ribonuclease that induces apoptosis in breast cancer cells associated with activation of MAPKs and induction of caspase pathways. Apoptosis, 2012, 17, 377\u2013387.", "ArticleIdList": ["22134530"]}, {"Citation": "Weng JR; Bai LY; Chiu CF; Hu JL; Chiu SJ; Wu CY Cucurbitane triterpenoid from Momordica charantia induces apoptosis and autophagy in breast cancer cells, in part, through peroxisome proliferator-activated receptor gamma activation. Evid. Based Complement Alternat. Med, 2013, 2013, 935675.", "ArticleIdList": ["PMC3697288", "23843889"]}, {"Citation": "Zhang CZ; Fang EF; Zhang HT; Liu LL; Yun JP Momordica charantia lectin exhibits antitumor activity towards hepatocellular carcinoma. Invest New Drugs, 2015, 33, 1\u201311.", "ArticleIdList": ["25200916"]}, {"Citation": "Marino G; Niso-Santano M; Baehrecke EH; Kroemer G Self-consumption: The interplay of autophagy and apoptosis. Nat. Rev. Mol Cell Biol, 2014, 15, 81\u201394.", "ArticleIdList": ["PMC3970201", "24401948"]}]}], "History": [{"Year": "2018", "Month": "1", "Day": "1"}, {"Year": "2018", "Month": "4", "Day": "10"}, {"Year": "2018", "Month": "5", "Day": "25"}, {"Year": "2018", "Month": "6", "Day": "23", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "8", "Day": "3", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "6", "Day": "23", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "4", "Day": "26"}], "PublicationStatus": "ppublish", "ArticleIdList": ["29932035", "NIHMS1007504", "PMC6486373", "10.2174/1389203719666180622095800", "CPPS-EPUB-91209"]}}]}